Department of Microbiology and Molecular Genetics, Institute for Medical Research Israel-Canada (IMRIC), The Hebrew University of Jerusalem, Faculty of Medicine, POB 12272, 9112102, Jerusalem, Israel.
Department of Chemistry, University of Michigan, 930 North University Avenue, Ann Arbor, MI, 48109, USA.
Sci Rep. 2022 Feb 2;12(1):1788. doi: 10.1038/s41598-022-05681-2.
Histone deacetylases play important biological roles well beyond the deacetylation of histone tails. In particular, HDAC6 is involved in multiple cellular processes such as apoptosis, cytoskeleton reorganization, and protein folding, affecting substrates such as ɑ-tubulin, Hsp90 and cortactin proteins. We have applied a biochemical enzymatic assay to measure the activity of HDAC6 on a set of candidate unlabeled peptides. These served for the calibration of a structure-based substrate prediction protocol, Rosetta FlexPepBind, previously used for the successful substrate prediction of HDAC8 and other enzymes. A proteome-wide screen of reported acetylation sites using our calibrated protocol together with the enzymatic assay provide new peptide substrates and avenues to novel potential functional regulatory roles of this promiscuous, multi-faceted enzyme. In particular, we propose novel regulatory roles of HDAC6 in tumorigenesis and cancer cell survival via the regulation of EGFR/Akt pathway activation. The calibration process and comparison of the results between HDAC6 and HDAC8 highlight structural differences that explain the established promiscuity of HDAC6.
组蛋白脱乙酰酶在除了组蛋白尾部去乙酰化之外的许多生物学过程中发挥着重要作用。特别是,HDAC6 参与多种细胞过程,如细胞凋亡、细胞骨架重排和蛋白质折叠,影响如 α-微管蛋白、Hsp90 和 cortactin 蛋白等底物。我们应用生化酶促测定法来测量一组候选未标记肽上 HDAC6 的活性。这些肽用于校准基于结构的底物预测方案 Rosetta FlexPepBind,该方案以前曾成功预测过 HDAC8 和其他酶的底物。使用我们校准的方案和酶促测定法对报道的乙酰化位点进行全蛋白质组筛选,提供了这种混杂的、多方面酶的新的肽底物和潜在的新的功能调节作用途径。特别是,我们通过调节 EGFR/Akt 通路的激活,提出了 HDAC6 在肿瘤发生和癌细胞存活中的新的调节作用。HDAC6 和 HDAC8 之间的校准过程和结果比较突出了结构差异,这些差异解释了 HDAC6 已建立的混杂性。